Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Meador, K. J.
Right arrow Articles by Karim, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Meador, K. J.
Right arrow Articles by Karim, R.
Related Collections
Right arrow All Neuropsychology/Behavior
Right arrow All Epilepsy/Seizures
Right arrow Antiepileptic drugs

Neurology 2003;60:1483-1488
© 2003 American Academy of Neurology

Differential cognitive and behavioral effects of topiramate and valproate

K. J. Meador, MD, D. W. Loring, PhD, J. F. Hulihan, MD, M. Kamin, MD and R. Karim, PhD for the CAPSS-027 Study Group*

From the Department of Neurology (Drs. Meador and Loring), Medical College of Georgia, Augusta; and Ortho-McNeil Pharmaceutical (Drs. Hulihan, Kamin, and Karim), Raritan, NJ.

Address correspondence and reprint requests to Dr. Kimford J. Meador, Department of Neurology, Georgetown University Hospital, 1st Floor Bles, 3800 Reservoir Road, N.W., Washington, DC 20007; e-mail: kjm32{at}georgetown.edu

Objective: Cognitive effects have been reported during topiramate (TPM) treatment, but effects relative to standard antiepileptic drugs are unclear.

Methods: The authors compared TPM and valproate (VPA) added to carbamazepine (CBZ) in adults with partial seizures. A comprehensive neuropsychological test battery including cognitive, mood, and quality of life measures was used in this multicenter, randomized, double-blind study. After a 4-week baseline, study drug was titrated over 8 weeks to target dosages of 400 mg/d TPM, 2,250 mg/d VPA, or placebo and then maintained for an additional 12 weeks. The neuropsychological test battery was administered at baseline and at the end of titration and maintenance periods.

Results: Slightly more patients on TPM dropped out. Neuropsychological data at all three test periods were available for 62 patients. At the end of maintenance, effects of TPM and VPA were comparable, except for two variables (Symbol Digit Modalities Test and Controlled Oral Word Association Test), in which TPM had greater negative effects relative to VPA. The statistical differences appeared to be due in large part to a small subset of patients who were more negatively affected by TPM. Cognitive effects of TPM relative to VPA were greater at the end of titration than at the end of maintenance.

Conclusions: With adjunctive therapy at moderate dose escalation rate, the cognitive effects of TPM are slightly worse overall than VPA in patients who tolerate therapy over several months.




This article has been cited by other articles:


Home page
J. Neurosci.Home page
S. N. Rakhade, C. Zhou, P. K. Aujla, R. Fishman, N. J. Sucher, and F. E. Jensen
Early Alterations of AMPA Receptors Mediate Synaptic Potentiation Induced by Neonatal Seizures
J. Neurosci., August 6, 2008; 28(32): 7979 - 7990.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
K. J. Meador, D. W. Loring, V. J. Vahle, P. G. Ray, M. A. Werz, A. J. Fessler, P. Ogrocki, M. R. Schoenberg, J. M. Miller, and R. P. Kustra
Cognitive and behavioral effects of lamotrigine and topiramate in healthy volunteers
Neurology, June 28, 2005; 64(12): 2108 - 2114.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. C. Salinsky, D. Storzbach, D. C. Spencer, B. S. Oken, T. Landry, and C. B. Dodrill
Effects of topiramate and gabapentin on cognitive abilities in healthy volunteers
Neurology, March 8, 2005; 64(5): 792 - 798.
[Abstract] [Full Text] [PDF]


Home page
J Child NeurolHome page
B. F. D. Bourgeois
Determining the Effects of Antiepileptic Drugs on Cognitive Function in Pediatric Patients With Epilepsy
J Child Neurol, August 1, 2004; 19(1_suppl): S15 - S24.
[Abstract] [PDF]


Home page
J Child NeurolHome page
B. F. D. Bourgeois
Determining the Effects of Antiepileptic Drugs on Cognitive Function in Pediatric Patients With Epilepsy
J Child Neurol, January 1, 2004; 19(1_suppl): S15 - S24.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by AAN Enterprises, Inc.